References
- New standard for drug makers: Proving the cure is worth the cost New York Times Jan 18, 1993; 1
- Krakoff I H. The case for active treatment in patients with advanced cancer: Not everyone needs a hospice. CA—Cancer Clinicians 1979; 29(2)108–111
- Long S H, Gibbs J O, Crozier J P, Cooper D I, Newman J F, Jr., Larsen A M. Medical expenditures of terminal cancer patients during the last years of life. Inquiry 1984; 21: 315–326
- Bayer R, Callahan D, Fletcher J, Hodgson T, Jennings B, Monsers D, Sieverts S, Viatch R. The care of the terminally ill: Morality and economics. New Engl J Med 1983; 309: 1490–1494
- Stoll B A. Balancing cost and benefit in treatment of late cancer. Lancet 1988; 579–580
- Specter W D, Mor V. Utilization and charges for terminal cancer patients in Rhode Island. Inquiry 1984; 21: 328–337
- Kassakian M G, Bailey L R, Rinker M, Stewart C A, Yates JW. The cost and quality of dying A comparison of home and hospital. Nurse Pract 1979; 18–23
- Krakoff I H. Cancer chemotherapeutic and biologic agents. CA—Cancer J Clinicians 1991; 41: 264–278